Showing results (261-270 of 1,647) with videos related to
Sort By:
Pageof 165
Retrovirology|September 25, 2007
Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivoPaul R Gorry, Dale A McPhee, Erin Verity, et al.Retrovirology|November 6, 2008
Intragenic transcriptional cis-activation of the human immunodeficiency virus 1 does not result in allele-specific inhibition of the endogenous geneAlex De Marco, Chiara Biancotto, Anna Knezevich, et al.Retrovirology|November 6, 2008
Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperationFrançoise Moreau-GachelinRetrovirology|September 13, 2008
RNA silencing and HIV: a hypothesis for the etiology of the severe combined immunodeficiency induced by the virusLinda B LudwigRetrovirology|December 19, 2008
Integrase and integration: biochemical activities of HIV-1 integraseOlivier Delelis, Kevin Carayon, Ali Saïb, et al.Retrovirology|December 20, 2008
Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infectionMichael M Lederman, Robin Jump, Heather A Pilch-Cooper, et al.Retrovirology|March 11, 2009
The Spanish HIV BioBank: a model of cooperative HIV researchIsabel García-Merino, Natividad de Las Cuevas, José Luis Jiménez, et al.Retrovirology|May 8, 2009
TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cellsSandra Thibault, Rémi Fromentin, Mélanie R Tardif, et al.Retrovirology|May 21, 2009
Memories of John N. Brady: scientist, mentor and friendCynthia A Pise-Masison, Susan J MarriottRetrovirology|June 3, 2009
"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescenceAndrea Savarino, Antonello Mai, Sandro Norelli, et al.Pageof 165